A. G. Petrov, G. Glembotskaya, O. Khoroshilova, Y. Sashko, V. A. Semenikhin
{"title":"CONCEPTUAL MODELS FOR THE FORMATION AND EVALUATION OF THE QUALITY OFPHARMACY ORGANIZATIONS","authors":"A. G. Petrov, G. Glembotskaya, O. Khoroshilova, Y. Sashko, V. A. Semenikhin","doi":"10.30809/solo.4.2022.3","DOIUrl":null,"url":null,"abstract":"The review considers conceptual models for the formation and evaluation of the quality of pharmacy organizations. The formation and evaluation of the quality of work of a pharmacy organization depends on a set of factors, in particular on the intellectual cap- ital of employees. It is shown that competitor management involves the use of such strategic components in the competition as the intellectual capital of employees of a pharmacy organization, contributing to the competitiveness of the organization in the pharmaceutical market and reducing risk events.","PeriodicalId":266512,"journal":{"name":"Modern organization of drug supply","volume":"60 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern organization of drug supply","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30809/solo.4.2022.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The review considers conceptual models for the formation and evaluation of the quality of pharmacy organizations. The formation and evaluation of the quality of work of a pharmacy organization depends on a set of factors, in particular on the intellectual cap- ital of employees. It is shown that competitor management involves the use of such strategic components in the competition as the intellectual capital of employees of a pharmacy organization, contributing to the competitiveness of the organization in the pharmaceutical market and reducing risk events.